Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | Rapid infusion treatment of MM

Alessandro Gozzetti • 15 Sep 2019
IMW 2019
Multiple Myeloma Antibodies Daratumumab

Alessandro Gozzetti, MD, PhD, Sense Univeristy Hospital, Siena, Italy, outlines the efficacy of rapid infusion of daratumumab in multiple myeloma (MM) patients, speaking at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Alessandro Gozzetti

1:31
Early relapse prediction in myeloma treated with novel agents
Alessandro Gozzetti • 24 Feb 2021
1:37
FORTE: MRD negativity as key prognostic factor in NDMM
Alessandro Gozzetti • 24 Feb 2021
2:09
DART4MM: daratumumab in myeloma patients with VGPR to first-line therapy
Alessandro Gozzetti • 24 Feb 2021
2:41
Effect of daratumumab on MRD measured by NGF in myeloma
Alessandro Gozzetti • 27 Nov 2020

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals